FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR [Yahoo! Finance]
SIEMENS AG SPONS ADR (SIEGY)
NASDAQ:AMEX Investor Relations:
siemens.com/investor
Company Research
Source: Yahoo! Finance
Reserve) delivers therapeutic outcomes comparable to those achieved with pressure wire–based FFR. Positive non-inferior result validates angiography–based vFFR as a safe and effective alternative for guiding revascularization Paves the way for reimbursement of less invasive testing for patients with intermediate coronary stenoses FAST III is a study sponsored by the European Cardiovascular Research Institute, supported by research grants from industry partners Siemens Healthineers and Pie Medical Imaging. MAASTRICHT, Netherlands March 29, 2026 /PRNewswire/ -- Pie Medical Imaging, a global leader in cardiac imaging analysis Solutions announces the result of the FAST III trial, presented during the Late-Breaking Clinical Trials session at the Congress of the American College of Cardiology (ACC) 2026 and published in the New England Journal of Medicine. The trial confirms non-inferiority of revascularization guided by CAAS vFFR to revascularization guided by pressure wire-based F
Show less
Read more
Impact Snapshot
Event Time:
SIEGY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SIEGY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SIEGY alerts
High impacting SIEMENS AG SPONS ADR news events
Weekly update
A roundup of the hottest topics
SIEGY
News
- Siemens Healthineers Flags Bigger FX, Tariff Headwinds in Q2 Pre-Close Update, Reiterates Outlook [Yahoo! Finance]Yahoo! Finance
- Varian TrueBeam Receives FDA Clearance for Low-Dose Radiotherapy for Adults with Medically Refractory Osteoarthritis [Yahoo! Finance]Yahoo! Finance
- Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available [Yahoo! Finance]Yahoo! Finance
- Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now AvailableGlobeNewswire
- Siemens launches Fuse EDA AI Agent for automation across semiconductor, 3D IC and PCB system workflowsPR Newswire